SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-18-016705
Filing Date
2018-07-10
Accepted
2018-07-10 16:05:30
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A arct-20fa_20171231.htm 20-F/A 108978
2 EX-4.14 arct-ex414_7.htm EX-4.14 569357
3 EX-12.3 arct-ex123_8.htm EX-12.3 3827
4 EX-12.4 arct-ex124_6.htm EX-12.4 3838
  Complete submission text file 0001564590-18-016705.txt   687106
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-35932 | Film No.: 18947024
SIC: 2834 Pharmaceutical Preparations